[Chronic radiodermatitis after heart catheterization: the contributing role of ciprofibrate (Lipanor)?].
BACKGROUND
Radiodermatitis after cardiac catheterization procedures has been reported in only a few cases in the literature. This side effect may not however be uncommon after long or repeated endocavitary explorations.


METHODS
We observed a case of chronic radiodermatitis which developed after cardiac catheterization, in a patient treated with corticosteroids and ciprofibrate for lupus. The patient had undergone only one heart catheterization. A second catheterization performed when the patient had stopped ciprofibrate did not provoke new lesions.


CONCLUSIONS
This observations would suggest that ciprofibrate could participate as a radiosensitizing factor in the development of radiodermatitis.
Gironet
N
N
Service de Dermatologie, CHU Tours.
Jan
V
V
Machet
M C
MC
Machet
L
L
Lorette
G
G
Vaillant
L
L
D006328:Cardiac Catheterization / Q000009:adverse effects*; D002908:Chronic Disease; D002995:Clofibric Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D058607:Fibric Acids; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D011838:Radiation-Sensitizing Agents / Q000009:adverse effects*; D011855:Radiodermatitis / Q000209:etiology*
D058607:Fibric Acids; D005938:Glucocorticoids; D000960:Hypolipidemic Agents; D011838:Radiation-Sensitizing Agents; D002995:Clofibric Acid; C019304:ciprofibrate; D011241:Prednisone